TotalMarketCap

Soligenix

SNGXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$7.252 M

$0.33 -5.61%

Close of 6 Nov 2026

As of 6 Nov 2026, Soligenix (SNGX) has a market capitalization of $7.25M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$119.4K

#3563 by revenue

Earnings

-$11.1M

Loss-making

Shares outstanding

23,368,754

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #430Alzamend NeuroALZN$7.38M
  2. #431Vistagen TherapeuticsVTGN$7.37M
  3. #432SoligenixSNGX$7.25M
  4. #433InMed PharmaceuticalsINM$7.14M
  5. #434Aprea TherapeuticsAPRE$7.03M

What if Soligenix were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,297,324

Per share 3,893,529× higher

Bitcoin $1.53T

$70,195.93

Per share 210,672× higher

Apple $5.02T

$230,446.68

Per share 691,617× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Soligenix are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.